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ABSTRACT
Rap1 is an essential DNA-binding factor from the
yeast Saccharomyces cerevisiae involved in tran-
scription and telomere maintenance. Its binding to
DNA targets Rap1 at particular loci, and may
optimize its ability to form functional macromolecu-
lar assemblies. It is a modular protein, rich in large
potentially unfolded regions, and comprising BRCT,
Myb and RCT well-structured domains. Here, we
present the architectures of Rap1 and a Rap1/DNA
complex, built through a step-by-step integration of
small angle X-ray scattering, X-ray crystallography
and nuclear magnetic resonance data. Our results
reveal Rap1 structural adjustment upon DNA
binding that involves a specific orientation of the
C-terminal (RCT) domain with regard to the DNA
binding domain (DBD). Crystal structure of DBD in
complex with a long DNA identifies an essential
wrapping loop, which constrains the orientation of
the RCT and affects Rap1 affinity to DNA. Based on
our structural information, we propose a model for
Rap1 assembly at telomere.
INTRODUCTION
Yeast Rap1 (Repressor Activator Protein 1) is an
abundant essential DNA-binding protein that plays
multiple functional roles in vivo, and is found at pro-
moters, silencers and telomeres (1,2). It is a key transcrip-
tional activator of many coregulated genes (3), a
modulator of chromatin structure at numerous yeast pro-
moters (4), a repressor that silences transcription at HML,
HMR and telomeres (5,6), and an essential telomeres com-
ponent (7,8). Its association to DNA transcription sites
affects nucleosome occupancy, and chromatin structure
and dynamics (4,9). Rap1 activates transcription at
binding sites that can be distant by >300bp from the
activated genes, in collaboration with other
DNA-associated proteins (3,4,10). Rap1 tightly and inde-
pendently binds the double-stranded telomeric DNA with
an average frequency of one protein every 18bp (11–13). It
recruits functional partners essential and speciﬁc for either
negative regulation of telomere elongation, transcriptional
repression or inhibition of non-homologous end joining
(NHEJ) (14, 15).
The initiation of Rap1 functions relies on its inter-
action with DNA. DNA consensus sequences have
been published which consist of 12–14bp (10,16,17).
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RYACAYM includes two tandem half-sites ACACC or
ACAYC and ACATY or ACAYM at bases 1–6 and 9–13
(12,17), although thermodynamic mapping of Rap1
binding includes three additional bases located immediate-
ly at the 50 of this sequence (18). Rap1 not only binds this
sequence with an extreme stability (19,20), but also toler-
ates large variation in the sequence, particularly in the
second half-site (2,10,20). In addition to speciﬁc DNA
binding, Rap1 is able to promote modiﬁcations of the
conformation of its target DNA site, including bending,
untwisting and quadruplex formation (G4 DNA)
(11,21,22). By its ability to promote single-strand
invasion (23), Rap1 appears functionally related to the
mammalian TRF2, which is known to promote t-loop
in vitro (24).
Mapping studies on Rap1 have identiﬁed a N-terminal
region that includes a BRCT domain, a double-Myb DNA
binding domain (DBD), and a regulatory C-terminal
domain (RCT), which directly interacts with several func-
tional partners (1) (Figure 1A). In addition to these three
domains, 40% of Rap1 peptidic chain corresponds to pre-
dicted unstructured regions. The ﬁrst 279 amino acids of
the protein, which include the BRCT domain, can be
deleted without affecting any known function (3),
although yeast two-hybrid experiments have shown that
this region is required for the interaction with the tran-
scription factor Gcr1 (25). The N-terminal and C-terminal
parts are dispensable for chromatin opening (26), or inter-
action with nucleosomal binding sites (9). The unstruc-
tured linker between DBD and RCT includes a region
required for transactivation (residues 630–695) (27) and
a toxicity region (residues 598–616) (28). The RCT is
required for the negative feedback loop that represses
telomere elongation by telomerase (29,30), and for the
establishment of a silent chromatin near telomeres
(6,31). It interacts with the proteins Rif1, Rif2, Sir3 and
Sir4. Rif1 and Rif2 are required for the inhibition of
telomere elongation through different mechanisms
(15,32–35). Sir3 and Sir4 establish transcriptional
silencing, which also requires Sir2, a conserved histone
deacetylase (36). The binding of the Rif and Sir proteins
to RCT appears to be mutually exclusive (37,38). Rif2 and
Sir4 are required for NHEJ inhibition, although protec-
tion against NHEJ is also observed with a DBD–RCT
construct of Rap1 in the absence of Rif2 and Sir4 (15).
The presence in Rap1 of several domains involved in
speciﬁc interactions and linked by ﬂexible regions
suggests a high structural plasticity of this molecule as
part of its functional competence. Recent electron micros-
copy studies have provided the ﬁrst information about
Rap1 architecture, which adopts a pseudo-ring conform-
ation in the absence of DNA (13,39). The X-ray structure
of the DBD in interaction with a DNA fragment is avail-
able (12), as well as that of the C-terminal domain (38,40),
and the NMR structure of the BRCT domain (41).
Despite these studies, the structural determinants
underlying the wide range of functions that Rap1 is able
to fulﬁll are still poorly understood.
A crucial step to understand the role of Rap1 plasticity
is to access to its whole architecture in complex with
DNA. The size of Rap1 together with its high content of
unstructured regions requires complementary approaches
to characterize its 3D structure (42). Our approach inte-
grates structural information obtained from SAXS, X-ray
crystallography and NMR. We combined SAXS with ana-
lytical ultracentrifugation (AUC) using three different
constructs of Rap1: DBD–RCT, BRCT–DBD–RCT and
full-length protein. This enabled to step-by-step build the
architecture of the whole molecule and of its complex with
DNA, and revealed conformational adjustment upon
DNA binding. The crystal structure of the DBD in
complex with a 30bp DNA provided the structural deter-
minants of Rap1 conformational adjustment upon DNA
binding. Finally, NMR titration of the RCT with
full-length Rif2 and a Sir3 peptide highlighted partially
overlapping surfaces, which remain accessible in the
Rap1/DNA complex.
MATERIALS AND METHODS
Sample preparation
The 6His-tagged Rap1[1–224], Rap1[117–224], Rap1[117–352],
Rap1[1–827] WT or mutant Y592A–K597A and 591–
597, Rap1[117–827], Rap1[358–827] and Rap1[675–827] were
cloned into pETM-13 expression vector and expressed in
Escherichia coli BL21(DE3) Star strain grown overnight at
20 C after IPTG induction at [IPTG]=0.5mM. The
proteins were puriﬁed using afﬁnity chromatography
with HisTrap column (GE Healthcare), cation exchange
chromatography with ResourceQ columns (GE
Healthcare), afﬁnity chromatography HiTrap Heparine
column (GE Healthcare) and size exclusion chromatog-
raphy, using Superdex200 and Superdex75 column (GE
Healthcare). Double-strand DNA were prepared using
single strand oligonucleotides ordered at Eurogentec,
and further puriﬁed using anion exchange chromatog-
raphy with MonoQ 10/100 GL column (Amersham).
Puriﬁed single-strand oligonucleotides were hybridized
by mixing equimolar ratio of complementary DNA
strands, heated to 96 C for 5min, and slowly cooled over-
night. Complexes between DNA and Rap1[1–827],
Rap1[117–827] or Rap1[358–827] were formed by mixing
equimolar ratio of protein/DNA, and puriﬁed by size ex-
clusion chromatography using Superdex200 column. The
different oligonucleotides and protein constructs used in
the study are summarized in Supplementary Table S1.
SAXS data collection, analysis and models construction
Rap1[1–827], Rap1[117–827], Rap1[358–827] alone or in
complex with DNA were prepared in the same storage
buffer and same concentration than for AUC experiment
(Supplementary Methods). All data were collected on
SWING Beamline using either the sample changer or the
online HPLC system (43) in the case of Rap1[1–827] or
Rap1[1–827]/DNA complex (Supplementary Figure S1A
and B). The data were analyzed using FOXTROT
(from SWING beamline) and PRIMUS (Primary
Analysis and Manipulations with Small Angle Scattering
DATA) from ATSAS 2.1 (44), from which Guinier
and normalized Kratky plots (45) were generated
3198 Nucleic Acids Research, 2012,Vol.40, No. 7Figure 1. SAXS analysis of Rap1 and Rap1–DNA complex. (A) Schematic boxing of Rap1 functional domains. (B–E) Cross-validated models from
SAXS data, calculated with BUNCH (48), with ﬁt and Chi residual of Rap1[358–827] (B), Rap1[358–827]/DNA (C), Rap1 (D) and Rap1/DNA (E). The
color code of domains is the same than in (A). Chi=1/(N 1) ˇ(
P
((Iexp cxIth)/sigma(Iexp))
2).
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scattering curves, the pair-distribution functions were
computed using GNOM (46), leading to the radius of gyr-
ation Rg, and the maximal distance Dmax (Supplementary
Figure S1D, Table 1). The molecular weights of the par-
ticles were derived from the extrapolated intensity at the
origin I0 (Table 1). In the cases of the proteins alones,
the program DAMMIN (47) was used to generate the
low-resolution ab initio shape envelops, which were
superimposed and averaged using DAMAVER (44)
(Figure S1E). To calculate the models, we used PDB
coordinates from the RCT X-ray structure (entry 3CZ6,
38) and from our crystal structure of DBD/DNA for the
three constructs, and from the BRCT NMR structure
(entry 2L42, 41) for Rap1 full length and Rap1[117–827].
The models were calculated in an iterative manner with
the program BUNCH (48) and cross-validated with AUC
sedimentation coefﬁcients (see Supplementary Methods
for detailed procedure and Table 1).
Crystallization and structure determination
Initial crystallization conditions were obtained at PF6
(Institut Pasteur, Paris, France) and further optimized in
our laboratory. The most suitable crystals were obtained
using seating drop vapor diffusion at room temperature,
with a concentration of Rap1[358–827]/DNA complex
between 3.3 and 5.5mg/ml, in a solution containing
100mM Tris–HCl pH 8.0, 20% (v/v) PEGmme-550,
100mM CaCl2 and 5% (v/v) glycerol. Native diffraction
data were collected on PX1 beamline at SOLEIL synchro-
tron, and reduced with XDS (49). The structure was
solved by molecular replacement with PHASER (50),
using 1IGN pdb entry as model probe (12), and reﬁned
with BUSTER5 (51). Electron density and SDS page gel
analysis revealed that Rap1[358–827] construct was partly
degraded and that in addition to the 31-bp oligonucleo-
tide, only the DBD moiety and part of DBD–RCT linker
was present in the crystals. Statistics of the data collection,
reﬁnement and model validation are shown in Table 2.
Directed-mutagenesis for the in vivo experiments
RAP1 sequence (from 676bp before the ATG to 427bp
after the STOP codon) was cloned into pRS414 plasmid.
Introduced mutations were Y592A (GCT instead of TAT)
and K597A (GCT instead of AAG) for the double
mutant, a 21-bp deletion that lead to the absence of
residues 591–597 for the deletion mutant and R580A
(GCT instead of AGG) for the single mutant. These
plasmids, together with a plasmid encoding wild-type
Rap1, were introduced in yeast strain Lev559 (W303-1a
background MAT  ade2-1 trp1-1 ura3-1 leu2-3,112
his-3-11,15 can1-100 RAD5 rap1-(D)::KANr
pACE1-UBR1 pACE1-ROX1) (52).
Western blot
Exponentially growing cells in synthetic medium lacking
tryptophan and supplemented or not with 400mM CuSO4
during 6h were subjected to protein extraction. Proteins
were extracted at 95 C in urea 8M, SDS 2% and Tris–
HCl pH 7.5 100mM followed by vortexing at 2500 r.p.m.
with glass beads. About 3mg of total extract were loaded
Table 1. Analytical ultracentrifugation, SAXS analysis and cross-validation of SAXS models
Construct Rap1[358–827] Rap1[117–827] Rap1 Rap1[358–827]/DNA Rap1[117–827]/DNA Rap1/DNA
Th. MW (kDa) 55 82 94 67 94 105
Partial speciﬁc
volume (ml/g)
0.717 0.712 0.710 0.689 0.693 0.693
AUC [Sample] (mg/ml) 0.55, 1.1, 2.2 0.82, 1.64, 3.11 0.56, 0.94, 1.4,
1.88, 2.81, 3.74
0.67, 1.35, 2.02 0.56, 0.94, 1.88, 2.81 0.63, 1.06, 2.12,
3.17, 4.23
MW (kDa) 55 82 94 67 94 106
Sed coef (S0,W,20) 3.6 3.8 3.9 4.2 4.3 4.2
f/f0 1.5 1.9 2.0 1.6 2.0 2.0
SAXS [Sample] (mg/ml) 1, 3.2 1.8, 2.5 1.1
a 9 0.7, 1.4, 2.8, 4.1 1.2
a
Rg (A ˚ ) 32.7 58.1 67.4 40.6 71.6 72.4
Dmax (A ˚ ) 120 224 260 162 275 260
Calc. sed. Coef. 3.6 3.8 4.0 4.2 4.3 4.2
Table 2. Statistics of the diffraction data collection, reﬁnement and
model validation
Data collection
Wavelength (A ˚ ) 0.98
Space-group P212121
Diffraction limits (last shell) 2.95A ˚ (3.13A ˚ –2.95A ˚ )
Unit cells (axbxcxaxbxg) 40.6 102.9 116.8
90 90 90
Rmerge 0.138 (0.688)
Number of unique reﬂections 9831
I/s 14.32 (3.39)
Completeness 0.901 (0.688)
Molecular replacement LLG=1305.76
Reﬁnement Buster5
Resolution 2.95A ˚
Rwork 0.1923
Rfree 0.2650
Figure of merit 0.869
Number of residues 223
Number of bases 62
Number of water molecules 6
RMSD bond 0.0010
RMSD angles 1.48
Average B-factor (protein, A ˚ 2)6 2
Average B-factor (DNA, A ˚ 2) 100
Average B-factor (residues 675–601, A ˚ 2)6 9
PDB entry 3UKG
3200 Nucleic Acids Research, 2012,Vol.40, No. 7on 4–12% NuPage gel (Invitrogen
TM), and then blotted
on a Hybond-P membrane (Amersham). Rap1 was
detected with RAP1-Y-300 rabbit polyclonal IgG from
Santa Cruz Biotechnology.
RESULTS
Orientation of Rap1 RCT is modulated upon DNA
binding
The overall structural organization of free Rap1 was
compared with that of Rap1 bound to DNA by using
analytical ultracentrifugation and small angle X-ray scat-
tering techniques. Three different constructs were tested:
Rap1[358–827], Rap1[117–827] and Rap1 full-length (Rap1).
Rap1[358–827] includes the DBD, the toxicity region, the
transcription activation region and the RCT domain
(Figure 1A), and corresponds to the required and sufﬁ-
cient region of Rap1 for telomere associated functions
(53). The long N-terminal moiety Rap1[1–357] is predicted
as ﬂexible, and was built in two steps using the construct
Rap1[117–827] (including BRCT, DBD and RCT domains),
and Rap1 full-length (Rap1). The molecular weights
derived from Guinier analyzes of the SAXS data
and the sedimentation coefﬁcient distribution proﬁles
from analytical ultracentrifugation experiments reveal no
sample aggregation, and conﬁrmed that these three con-
structs of Rap1 are monomeric in solution and that Rap1/
DNA complexes have a one to one stoechiometry
(Supplementary Figures S1C, S2 and Table 1).
The use of Kratky plots to detect macromolecular ﬂexi-
bility from SAXS data is well established and extensively
used (54–56). The bell shapes of Kratky plots calculated
for Rap1[358–827] free and in complex with DNA reﬂect
their compact organization (Supplementary Figure S1D).
The pair distribution proﬁle corresponds to a globular
molecule in the case of free Rap1[358–827], and to an
elongated molecule in the case of its complex with DNA
(Supplementary Figure S1E). Average structures were
calculated with BUNCH (48), and structures consistent
with SAXS and AUC data were further selected
(Supplementary Methods, Table 1). These structures
of Rap1[358–827] and Rap1[358–827]/DNA are characterized
by residual chi values of 0.87 and of 0.64, respectively
(Figure 1B and C). Interestingly, the RCT orientation
with regard to the DBD is different when the molecule
is alone or in complex with DNA; this implies a conform-
ational adjustment of Rap1[358–827] upon DNA binding.
Unlike in the case of Rap1[358–827], the Kratky plots of
both Rap1[117–827] and Rap1, free or in complex with
DNA, correspond to partially unstructured molecules
(Supplementary Figure S1D), and pair distribution
proﬁles are characteristic of elongated molecules
(Supplementary Figure S1E). Calculated ab initio enve-
lopes reveal a compact shape for Rap1[358–827], and a pro-
gressive elongation for Rap1[117–827] and Rap1
(Supplementary Figure S1F). Superposition of the three
envelops highlights structural conservation of a compact
region that could be attributed to region [358–827]
(Supplementary Figure S1F). The frictional ratios
measured by AUC arise from 1.5 to 1.9 and 2.0 in
Rap1[358–827], Rap1[117–827] and Rap1, respectively,
showing the transition from a compact structure for
Rap1[358–827] to elongated structures for Rap1[117–827] and
Rap1 (Table 1, Supplementary Figure S2). The average
structures of Rap1[117–827] and of Rap1, free or in
complex with DNA, remain compact in region 358–827,
the N-terminal half is extended in all models
(Supplementary Figures S3A and B, S1D–E), and the
overall shapes of the molecules free and in complex
with DNA are similar (Figure S3C–D). We calculated the-
oretical SAXS curves using region [358–827] from
Rap1[117–827] and Rap1 models free or in complex with
DNA, and compared them respectively with experimental
Rap1[358–827] or Rap1[358–827]/DNA SAXS curve. We
observed a better ﬁt between theoretical and experimental
curves in the case of DNA complexes, although super-
position of region [358–827] from free Rap1[358-827],
Rap1[117-827] and Rap1 reveals similar overall shapes
(Supplementary Figure S4A and B). Superposition of
region 358–827 on the DBD domain from the three
Rap1 constructs shows that the relative orientation of
RCT with regard to DBD ﬂuctuates when the protein is
free, whereas it is conﬁned to a limited area in the DNA
complex (Supplementary Figure S4C–D). Moreover, the
orientation of the RCT domain does not depend on the
presence of the N-terminal moiety of the molecule.
In summary, comparison of the average structures from
our three constructs highlights two important points: (i)
the compact conformation of region 358–827 does not
depend on the presence of the N-terminal moiety; (ii) the
interaction with DNA is associated with a reorientation of
the RCT and a decreased ﬂexibility.
Structural determinants of Rap1 organization upon
DNA binding
The reorientation of the RCT domain with regard to the
DBD upon DNA binding suggests that the overall con-
formation of Rap1 is driven by important structural deter-
minants located in the DBD–DNA moiety. The available
high-resolution crystal structure of DBD in complex with
a 19bp double-stranded DNA shows that the two Myb-
domains are tandemly arranged on the DNA so that each
is aligned to and makes similar contacts with the GGTGT
sequences of Rap1 binding site (12,57,58). However, due
to crystal packing interactions, the available structure
leaves uncertainty concerning the conformation of the
C-terminal loop of DBD (12), which limits our knowledge
about the RCT orientation with respect to the DBD.
To clarify this information, we solved the X-ray structure
of Rap1DBD in complex with a 31bp double stranded
DNA oligonucleotide (Table 2). The oligonucleotide
length enlarges the binding interface, and reduces the
crystal packing constraints that tighten the DNA con-
formation. The superimposition of our structure with
the available Rap1DBD/DNA complex coordinates (PDB
entry 1IGN, 12) leads to a rms deviation of 1.77A ˚ .A s
expected, Rap1DBD exclusively binds the two hemi-sites
spaced by three nucleotides; the additional DNA region
remains free of protein (Figure 2A and B).
Nucleic Acids Research,2012, Vol.40, No. 7 3201The main novelty of our structure lies in the quality of
the deﬁnition of loop [565–601]. The 1IGN structure
lacks three protein regions: loops [482–512], [565–571]
and [579–586], and ends at position 594. In our structure,
the loop corresponding to [482–512] is still disordered
between residues 480–498. The [565–601] region (seven
residues longer than in 1IGN) is well deﬁned, and wraps
around the DNA molecule. It runs along DNA major
groove with no secondary structure element, and brings
the N and C-terminus extremities nearby, although
they are orientated in opposite directions (Figure 2A).
In addition, this wrapping loop is deeply engaged in
protein/protein and protein/DNA interactions, with a
total buried surface of 1508 A ˚ 2, corresponding to 37%
of its total surface. The interaction with DNA buries
2374 A ˚ 2 of the DBD, among which 642 A ˚ 2 comes from
the wrapping loop. The wrapping loop starts at region
565–571, lengthens helix 7 by one helical turn, and
forms a tight turn at residues 565–569 that directs the
loop back toward DNA major groove (Supplementary
Figure S5A). The interaction between the wrapping loop
and DNA involves segments 575–583 and 589–597.
Residues 575–583 interact with Ade19, Cyt20, Ade21
from C-rich strand and Gua8 from G-rich strand, and
Arg580 is deeply plugged in the major groove
(Supplementary Figure S5B). Region 589–597 interacts
with Cyt16 and Cyt17 from C-rich strand, and residues
Tyr592 and Lys 597 interact with helix 2 from Myb1.
These Myb1/wrapping-loop interactions close the clamp
formed by the wrapping loop (Figure 3A). Finally, the
N-terminal and C-terminal extremities of DBD are
oriented in opposite direction, in agreement with the ob-
servation provided by our SAXS analysis.
Rap1 wrapping loop is important for its functional
integrity and its binding to DNA
Our SAXS analysis together with the crystal structure
implies that the wrapping of Rap1 around DNA has im-
portant consequences regarding its overall conformation,
and its adjustment upon DNA binding. The physiological
relevance of the wrapping loop was addressed with three
Rap1 alleles mutated within the loop: Arg580 from the
ﬁrst segment was modiﬁed into alanine (rap1-R580A),
residues Tyr592 and Lys597 that lock the clamp were
replaced by alanines (rap1-Y592A; K597A), and the
A
B
Figure 2. Structural determinants of Rap1–DNA interaction. (A) Overall structure of Rap1–DBD in complex with DNA, with 1sigma level electron
density map in blue around the region corresponding to the wrapping loop (residues 565–601). H1–H7 labels highlights alpha-helices in sequential
order. The blue and red arrows indicate the respective directions of N- and C-terminal ends. (B) Zoom on Rap1 wrapping loop from Lys575 to
Asn601 (in green).
3202 Nucleic Acids Research, 2012,Vol.40, No. 7whole region 591–597 was deleted (rap1-591–597). These
constructs were introduced in Lev559, a strain encoding a
Rap1 degron protein that will be degraded upon copper
addition (14), allowing in vivo analysis of mutated Rap1
proteins. As shown in Figure 3B, rap1-R580A protein
level is identical to wild-type level but rap1-Y592A–
K597A and rap1-591–597 levels are slightly increased.
All strains display normal growth when rap1 degron is not
induced. Upon Cu
2+ addition, uncomplemented cells die
whereas cells complemented with wild-type RAP1 or with
the rap1-R580A allele grow normally (Figure 3C).
Interestingly, the rap1-Y592A–K597A and rap1-591–
597 alleles fail to fully compensate endogenous Rap1
loss, the rap1-D591–597 mutant displaying a more severe
growth defect. In the same way, ITC titration of Rap1
wild type or mutants Rap1[Y592A–K597A] and
Rap1[591–597] by DNA reveals a lower afﬁnity by a
factor of 2 or 5, respectively for each mutant as
compared to the wild type (Figure 3D, Supplementary
Table S3). Native gel migration proﬁles are similar for
both wild type and mutated Rap1/DNA complexes,
although the size and ﬂexibility of the molecule suggest
that changes in domain orientation remains possible
(Figure 3E). These analyses indicate that the region
[591–597] as well as residues 592 and/or 597 are important
if not essential for Rap1 function, and highlight the im-
portance of DBD wrapping loop and its clamp through
interactions with Myb1.
Orientation of C-terminal domain within Rap1/DNA
complex is compatible with its interaction with functional
partners Rif2 and Sir3
Two signiﬁcant features come from our analysis: (i) the re-
orientation of the RCT domain with regard to the
DBD upon DNA binding, (ii) the location of Rap1 N-
and C-terminal parts on opposite sides of the DNA
(Figure 1E). Numerous studies have shown that RCT
domain plays a crucial role in Rap1 partners recruitment
(6,15,29–35). We therefore checked if the conformation of
AB
C
E D
Figure 3. Functional importance of Rap1 wrapping loop. (A) Cartoon representation of C-terminal clamp region colored from conservation analysis
scores. Residues involved in C-terminal clamp are represented in sticks. Red and blue arrows highlight residues of the wrapping loop (red) that
interact with residues of Myb1 (blue). (B) Western blot comparing Rap1 amount in the different strains. Rap1 level in rap1-(D) cells complemented
with RAP1 (WT), rap1-Y592A;K597A, rap1-D591-597 and rap1-R580A alleles. The asterisk indicates the position of the tagged Rap1 degron, which
disappears upon Cu
2+ addition. (C) Ability of the rap1 alleles to complement Rap1 loss. The 10-fold serial dilution of exponentially growing cells was
spotted on synthetic medium plates with or without 400mM CuSO4. The plates were photographed after 3 days of growth at 30 C. (D) ITC titration
of Rap1, Rap1[Y592A–K597A] or Rap1[591–597] by DNA. (E) EMSA experiments using 8mM DNA in the presence or not of 4mM of Rap1,
Rap1[Y592A–K597A] or Rap1[591–597]. Cplx indicates the position of DNA/protein complex; DNA indicates free DNA.
Nucleic Acids Research,2012, Vol.40, No. 7 3203Rap1/DNA complex and the orientation of RCT was
compatible with its interaction with functional partners
in solution. We performed NMR titrations of
15N-labeled Rap1[675–827] with a Sir3[450–487] interacting
peptide designed on the basis of previous double-hybrid
experiments (59) and Rif2 full length (Supplementary
Methods, Supplementary Figure S6). After assigning the
NMR spectra of Rap1[675–827] (Supplementary Methods,
Figure S6A), we identiﬁed residues whose peaks were
affected upon titration with Sir3[450–487] and Rif2. The re-
sulting surfaces are consistent with previous studies
(38,40), and are partly overlapping (Supplementary
Figure S7A). In addition, these Sir3 and Rif2 interacting
surfaces on Rap1 RCT are still accessible when positioned
onto the average structure of Rap1 full length in complex
with DNA (Supplementary Figure S7B).
DISCUSSION
Interaction of Rap1 with DNA is associated to structural
adjustments
The integrated structural biology study presented here
allows for the ﬁrst time to build a complete molecular
image of the average architecture of Rap1 in solution
free and in complex with DNA, despite its modular or-
ganization and ﬂexible character. In the absence of DNA
the molecule is elongated and partially disordered. The
N-terminal part is particularly extended and poorly
organized, whereas the DBD–RCT is more compact.
The combined analysis of the three different constructs
conﬁrms the modular character of the molecule and also
shows that the relative orientation of the globular
domains ﬂuctuates one with respect to the others.
Comparison of our results with available electron micros-
copy images of Rap1 is of particular interest since our
approach describes the average extended conformation,
whereas high-resolution microscopy highlights the more
frequent pseudo-ring (13,39) or V-shape (22) conform-
ations. NMR titrations, ITC and gel ﬁltration experiments
conﬁrmed that there is no preferential interaction between
the N-terminal part of Rap1 and the RCT domain or
DBD–RCT region that could stabilize a pseudo-ring
structure of Rap1 (details in Supplementary Methods
and Supplementary Figure S8). The extended and
modular arrangement of free Rap1, as well as the accessi-
bility of the Myb domains, is favorable to its interaction
with DNA. However, modeling a DNA/Myb interaction
using the domain organization of free Rap1 leads to
sterical hindrance between DNA and RCT domain
(Figure 4A). This shows that the average domains organ-
ization of Rap1 needs to adjust upon DNA binding, in
agreement with the conformation observed for Rap1 in
complex with DNA (Figures 1E and Supplementary
Figure S3B). The conformational adjustment of Rap1
upon DNA binding leads to an orientation of the N-
and C-terminal parts of the molecule in opposite direc-
tions almost perpendicular to the DNA axis (Figure 1E).
Our crystal structure of DBD/DNA reveals that such con-
formational adjustment is probably driven by a loop
located at position 575–601 of DBD that wraps DNA
molecule (Figure 2A). We observed a reorientation of
the RCT relatively to the DBD due to DNA binding,
and the orientation of the RCT is more constrained with
regard to the DBD. Furthermore, NMR titration of
15N-labeled Rap1[675-827] with the full length protein
Rif2, and a Sir3[450-483] peptide leads to interacting
surfaces, which remain solvent-exposed in our average
structure of Rap1/DNA complex and thus accessible to
Rif2 and Sir3 (Figures S6 and S7). Therefore, we
propose that the orientation of the RCT in Rap1/DNA
complex may facilitate its interaction with its functional
partners, and the corresponding telomeric functions.
Remodeling of Rap1 involves its wrapping around DNA
The wrapping loop located at position 575–601 of DBD is
involved in extensive interactions with DNA, and in-
creases the surface involved in DNA binding by 25%. In
addition, its interaction with the ﬁrst Myb of the DBD
clamps the molecule around DNA through two
residues (Tyr592 and Lys597) located at the tip of the
loop (Figures 2A and 3A). In vivo experiments using
yeast strains expressing mutants of Tyr592 and Lys597
or deletion of 591–597 segment highlight the functional
signiﬁcance of these residues (Figure 3B and C).
Importance of region 583–596 in Rap1 DNA binding
was previously observed using band shift assays (60). In
this publication, Kingsman’s group observed DNA
binding with Rap1 region 302–596, but not with region
302–583, and concluded that the DNA binding domain
ends within segment 583–596. In our study, we observe
that mutation of Rap1 at Tyr592 and Lys597, or
deletion of 591–597 segment affect its afﬁnity for DNA
by a factor of two and ﬁve respectively, although DNA
interaction is not fully abolished (Figure 3D and E).
Altogether, our results suggest that (i) the wrapping,
(ii) the clamp of the molecule at a speciﬁc position on
DNA molecule and/or (iii) the orientation of N- and
C-terminal part in opposite direction are essential for
Rap1 functional integrity. In fact, in the case of
telomere protection, chromatin opening, or interaction
with nucleosomal binding sites, the tight wrapping of
Rap1DBD is probably sufﬁcient since these functions can
occur in the absence of N- and C-terminal domains of the
molecule (9,26,29,36).
Toward a molecular model of telomere assembly
Combination of NMR results, crystal structure and SAXS
analysis allows us to build the overall architecture of Rap1
in interaction or not with double-stranded DNA. These
results highlight the modular character of Rap1, its struc-
tural plasticity that may facilitate its binding to DNA, and
a complete and tight wrapping of the molecule around
DNA that constraints the orientation of the C-terminal
fragment and may favor its interaction with its functional
partners (Figure 4A).
In a telomeric context, Rap1 binds independently to
each recognition site (11, 13). In the same way, our inter-
action studies show neither oligomerization of Rap1
(Supplementary Figure S2, Table 1), nor interdomain
interaction. In addition, the extended conformation of
3204 Nucleic Acids Research, 2012,Vol.40, No. 7the molecule bound to DNA, with its axis of elongation
almost perpendicular to the axis of the DNA molecule,
leaves accessible the nearby sites, and is compatible
with the binding and remodeling of a second molecule
(Figure 4B). On the basis of these data, we reconstituted
a molecular model of an 80 base pairs telomere with its
ﬁrst shell bound Rap1 molecules every 18 base pairs (11)
(Figure 4C). We observe that the 18bp spacing leads to a
high molecular density. Because of the use of a short DNA
in our study, the limit in detectable afﬁnities, and the tight
binding of Rap1–DBD at DNA, one cannot exclude that
transient interactions might occur between adjacent mol-
ecules. The proximity between Rap1 molecules may also
favor particular macromolecular assemblies at the second
A
B
C
Figure 4. Architecture of telomere ﬁrst shell macro-assembly. (A) Complete architecture of free Rap1, model of free Rap1 in interaction with DNA
and Rap1/DNA complex in interaction with a telomeric DNA, with the RCT surface involved in functional partners interactions, based on the
combination of SAXS analysis, crystal structure and NMR titration. DNA is represented in surface mode colored in grey and telomere hemi-site in
purple, BRCT in orange, DBD in green and RCT in red (with overall surface involved in Rif2 and Sir3 interaction in blue). The path of the
wrapping loop is indicated with a purple arrow. (B) Modeling of the interaction of a second Rap1 molecule along telomere. (C) Reconstitution of a
four Rap1 sites telomere along or in front of DNA ﬁber. Bound Rap1 molecules are represented in cartoon mode with different colors. Rap1 sites in
violet are spaced every 18bp.
Nucleic Acids Research,2012, Vol.40, No. 7 3205shell of telomere structure that involve Rap1 functional
partners. The formation of such molecular scaffolding
now needs to be documented at a structural level.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Methods, Supplementary Figures
S1–S8, Supplementary Tables S1–S3 and Supplementary
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